|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07K 5/00 | (2006.01) |
| C07K 1/00 | (2006.01) | ||
| C07K 14/00 | (2006.01) |
| (11) | Number of the document | 1434791 |
| (13) | Kind of document | T |
| (96) | European patent application number | 02804105.1 |
| Date of filing the European patent application | 2002-10-11 | |
| (97) | Date of publication of the European application | 2004-07-07 |
| (45) | Date of publication and mention of the grant of the patent | 2009-10-07 |
| (46) | Date of publication of the claims translation | 2010-01-25 |
| (86) | Number | PCT/US2002/032657 |
| Date | 2002-10-11 |
| (87) | Number | WO 2003/057134 |
| Date | 2003-07-17 |
| (30) | Number | Date | Country code |
| 328624 P | 2001-10-11 | US | |
| 414155 P | 2002-09-27 | US | |
| 269695 | 2002-10-10 | US |
| (72) |
OLINER, Jonathan, Daniel, US
MIN, Hosung, US
|
| (73) |
Amgen, Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Žmogaus angiopoetino-2 specifiškai prisirišantys agentai |
| SPECIFIC BINDING AGENTS OF HUMAN ANGIOPOIETIN-2 |
| Payment date | Validity (years) | Amount | |
| 2021-09-17 | 347.00 EUR |